Small and Medium-sized Enterprises (SMEs) working with photonics in life sciences markets can benefit from the support offered by CPI and other European partners, as part of the Horizon 2020 project EPRISE (Empowering Photonics through Regional Innovation Strategies in Europe). The 30 month long project, which finished at the end of June 2019, focussed on removing barriers to commercialisation for photonics SMEs in four market sectors in which Europe is a market leader, namely: medical technologies, pharmaceuticals, food and agriculture.

CPI, an independent technology innovation centre based in the North East, is celebrating 15 years of innovation across a range of different markets including pharmaceuticals, agritech, FMCG, automotive, energy and aerospace.

CPI is contributing its state-of-the-art facilities and capabilities to a Horizon 2020 project focused on creating an open-innovation test bed for the development and production of lightweight embedded electronics.

Following the launch of CPI’s new National Healthcare Photonics Centre, Tom Harvey, Healthcare Photonics Lead at CPI, looks at the facility’s long-term potential to support the medical technology (medtech) and healthcare markets.

Our entire economy is driven by consumption and disposal. This is fine – provided we use resources with the utmost efficiency and recover, reuse, remanufacture or recycle the valuable materials in our waste streams.

In the bioprocessing industry, fermentation is a unit operation in which microorganisms are grown so as to generate products.